Эндотелиопротективные эффекты резвератрола и его комбинаций с эналаприлом и лозартаном при экспериментальном моделировании дефицита оксида азота

Experimental researches endothelioprotective and cardioprotective effects of resveratrol and its combinations to enalapril and losartan are lead at the L-NAME-induced deficiency of nitrogen oxyde. Results specifying on distinct endothelioprotective and cardioprotective action of resveratrol are received by means of a complex of physiological, biochemical and morphological methods, at use as a kind of monotherapy as well in a combination with ATE-inhibitor enalapril and AT1-blocker losartan, that allows to recommend these combinations to wide clinical studying.